Healthcare Industry News: Smith & Nephew Endoscopy
News Release - March 9, 2006
Smith & Nephew Endoscopy Appoints Mullen to Lead US SalesANDOVER, Mass., March 9 (HSMN NewsFeed) -- Smith & Nephew's (NYSE: SNN ; LSE: SN ) Endoscopy division today announced the appointment of John Mullen as Vice President, U.S. Sales.
Mr. Mullen has been with Smith & Nephew since 1992, most recently serving as Endoscopy's VP, Spine. In that position, Mullen played a strategic role in spearheading the development and growth of the company's Spine product portfolio and expanding the business into International markets.
Prior to that Mullen served as Endoscopy's Business Manager for the United Kingdom (UK). In that role, Mullen was directly responsible for all aspects of operations and strategic direction, including P&L, business development, sales and marketing for the company's UK business.
Before joining Smith & Nephew, Mullen served as a sales representative for a physiotherapy organization. He holds a Master of Business Administration from Cambridge College, Cambridge, UK and an Honours Degree in Sports Science from Crewe and Alsager College, Cheshire, UK.
Mullen resides in Winchester, Mass., with his wife and children.
About Smith & Nephew:
Smith & Nephew (NYSE: SNN, LSE: SN) (http://www.smith-nephew.com) is a global medical technology business, specializing in Endoscopy, Orthopaedic Reconstruction, Orthopaedic Trauma and Advanced Wound Management products. Smith & Nephew ranks as the global leader in arthroscopy and one of the world's leaders in advanced wound management and is one of the fastest growing orthopaedics companies in the world.
Smith & Nephew is dedicated to helping improve people's lives. The company prides itself on the strength of its relationships with its surgeon and professional healthcare customers, with whom its name is synonymous with the highest standards of performance, innovation and trust. The company has more than 8,500 employees and operates in 33 countries around the world and generated sales of nearly $2.6 billion.
Forward Looking Statements
This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and operating margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward- looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Source: Smith & Nephew
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.